BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36277957)

  • 41. Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis.
    Satiya J; Mousa OY; Gupta K; Trivedi S; Oman SP; Wijarnpreecha K; Harnois DM; Corral JE
    Clin Exp Hepatol; 2020 Feb; 6(1):35-41. PubMed ID: 32166122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography.
    Dave M; Elmunzer BJ; Dwamena BA; Higgins PD
    Radiology; 2010 Aug; 256(2):387-96. PubMed ID: 20656832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis.
    Corpechot C; Carrat F; Gaouar F; Chau F; Hirschfield G; Gulamhusein A; Montano-Loza AJ; Lytvyak E; Schramm C; Pares A; Olivas I; Eaton JE; Osman KT; Dalekos G; Gatselis N; Nevens F; Cazzagon N; Zago A; Russo FP; Abbas N; Trivedi P; Thorburn D; Saffioti F; Barkai L; Roccarina D; Calvaruso V; Fichera A; Delamarre A; Medina-Morales E; Bonder A; Patwardhan V; Rigamonti C; Carbone M; Invernizzi P; Cristoferi L; van der Meer A; de Veer R; Zigmond E; Yehezkel E; Kremer AE; Deibel A; Dumortier J; Bruns T; Große K; Pageaux GP; Wetten A; Dyson J; Jones D; Chazouillères O; Hansen B; de Lédinghen V;
    J Hepatol; 2022 Dec; 77(6):1545-1553. PubMed ID: 35777587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
    Eaton JE; Talwalkar JA; Lazaridis KN; Gores GJ; Lindor KD
    Gastroenterology; 2013 Sep; 145(3):521-36. PubMed ID: 23827861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A clinical and pathological analysis of 22 cases of primary sclerosing cholangitis].
    Liu HH; Fu JL; Luo SQ; Sun YL; Dong JH; Guo TS; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):125-8. PubMed ID: 23663885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study.
    Poetter-Lang S; Messner A; Bastati N; Ringe KI; Ronot M; Venkatesh SK; Ambros R; Kristic A; Korajac A; Dovjak G; Zalaudek M; Hodge JC; Schramm C; Halilbasic E; Trauner M; Ba-Ssalamah A
    Eur Radiol; 2023 Dec; 33(12):9022-9037. PubMed ID: 37470827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.
    Tan N; Ngu N; Worland T; Lee T; Abrahams T; Freeman E; Hannah N; Gazelakis K; Madden RG; Lynch KD; Valaydon Z; Sood S; Dev A; Bell S; Thompson AJ; Ding JN; Nicoll AJ; Liu K; Pandya K; Gow P; Lubel J; Kemp W; Roberts SK; Majeed A
    Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38696372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evolving role of magnetic resonance techniques in primary sclerosing cholangitis.
    Selvaraj EA; Culver EL; Bungay H; Bailey A; Chapman RW; Pavlides M
    World J Gastroenterol; 2019 Feb; 25(6):644-658. PubMed ID: 30783369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [MRCP in primary sclerosing cholangitis].
    Weber C; Krupski G; Lorenzen J; Grotelüschen R; Seitz U; Rogiers X; Adam G
    Rofo; 2003 Feb; 175(2):203-10. PubMed ID: 12584620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnetic Resonance Imaging in Primary Sclerosing Cholangitis-Current State and Future Directions.
    Zenouzi R; Welle CL; Venkatesh SK; Schramm C; Eaton JE
    Semin Liver Dis; 2019 Jul; 39(3):369-380. PubMed ID: 31041791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
    Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
    Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spontaneous perforation of the common bile duct: an uncommon complication of primary sclerosing cholangitis.
    Dargent L; Lemoinne S; Louvion K; Iorio P; Corpechot C; Mouhadi SE; Vanderbecq Q; Chazouillères O; Arrivé L
    Eur Radiol; 2024 Mar; ():. PubMed ID: 38512493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary sclerosing cholangitis: diagnostic performance of MRI compared to blood tests and clinical scoring systems for the evaluation of histopathological severity of disease.
    Song C; Lewis S; Kamath A; Hectors S; Putra J; Kihira S; Bane O; Ahmad J; Babb J; Thung S; Taouli B
    Abdom Radiol (NY); 2020 Feb; 45(2):354-364. PubMed ID: 31844914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis.
    Ghafoor S; Germann M; Jüngst C; Müllhaupt B; Reiner CS; Stocker D
    Insights Imaging; 2022 Aug; 13(1):128. PubMed ID: 35939241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary sclerosing cholangitis: diagnosis, prognosis, and management.
    Singh S; Talwalkar JA
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):898-907. PubMed ID: 23454027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography.
    Vitellas KM; Keogan MT; Freed KS; Enns RA; Spritzer CE; Baillie JM; Nelson RC
    Radiographics; 2000; 20(4):959-75; quiz 1108-9, 1112. PubMed ID: 10903686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.
    Gauss A; Sauer P; Stiehl A; Rupp C; Krisam J; Leopold Y; Kloeters-Plachky P; Stremmel W; Gotthardt D
    Medicine (Baltimore); 2016 Apr; 95(17):e3510. PubMed ID: 27124059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography.
    Enns R; Eloubeidi MA; Mergener K; Jowell PS; Branch MS; Baillie J
    Can J Gastroenterol; 2003 Apr; 17(4):243-8. PubMed ID: 12704468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MR cholangiopancreatography in patients with primary sclerosing cholangitis: interobserver variability and comparison with endoscopic retrograde cholangiopancreatography.
    Vitellas KM; El-Dieb A; Vaswani KK; Bennett WF; Tzalonikou M; Mabee C; Kirkpatrick R; Bova JG
    AJR Am J Roentgenol; 2002 Aug; 179(2):399-407. PubMed ID: 12130441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.